SCHEMBL30211348

SCHEMBL30211348

CCCCCCCCCCCCCC=CC=CC(=O)O[C@H](CO)COP(=O)(O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 3/20 0.64
LPAR1 Q92633 8/20 0.54
ENPP2 Q13822 4/20 0.52
LPAR3 Q9UBY5 5/20 0.47
LPAR4 Q99677 2/20 0.47
LPAR5 Q9H1C0 2/20 0.47
LPAR2 Q9HBW0 2/20 0.47
CES2 O00748 1/20 0.47
LPAR6 P43657 1/20 0.47
TRPV1 Q8NER1 1/20 0.47
S1PR4 O95977 2/20 0.47
S1PR3 Q99500 2/20 0.47
S1PR5 Q9H228 2/20 0.47
PRKCA P17252 2/20 0.47
PRKCE Q02156 1/20 0.47
PRKCQ Q04759 1/20 0.47
PRKCD Q05655 1/20 0.47
S1PR2 O95136 1/20 0.47
ALDH1A1 P00352 1/20 0.47
TSPO P30536 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17435202 1.00 S1PR1 (0.64) S1PR1LPAR1ENPP2LPAR3LPAR4
SCHEMBL1295800 0.89 ENPP2 (0.57) S1PR1LPAR1ENPP2LPAR3LPAR4
SCHEMBL1295557 0.89 ENPP2 (0.57) S1PR1LPAR1ENPP2LPAR3LPAR4
SCHEMBL234397 0.88 ENPP2 (0.56) S1PR1LPAR1ENPP2LPAR3LPAR4
SCHEMBL3410348 0.88 ENPP2 (0.56) S1PR1LPAR1ENPP2LPAR3LPAR4
Phosphoric Acid SCHEMBL28535382 0.88 CNR1 (0.48) S1PR1PRKCAPRKCEPRKCQPRKCD
SCHEMBL1296721 0.85 ENPP2 (0.71) S1PR1LPAR1ENPP2LPAR3LPAR4
Phosphorylethanolamine SCHEMBL28542056 0.85 S1PR1 (0.47) S1PR1LPAR1ENPP2LPAR3LPAR2
SCHEMBL1295914 0.85 ENPP2 (0.71) S1PR1LPAR1ENPP2LPAR3LPAR4
SCHEMBL1296442 0.85 ENPP2 (0.71) S1PR1LPAR1ENPP2LPAR3LPAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025224196-A1 COMPOUNDS KING'S COLLEGE LONDON (GB) 2025-10-30 WO disclosed
US-20230027885-A1 TARGETING GENE AMPLIFICATION IN CANCER USING TRIPLEX FORMATION AS A THERAPEUTIC STRATEGY YALE UNIVERSITY (US) 2023-01-26 US disclosed
WO-2023288316-A1 METHOD OF USE FOR APOE PEPTIDES ANJI PHARMA (US) LLC (US) 2023-01-19 WO disclosed